CVS HEALTH Corp·4

Mar 2, 5:46 PM ET

Joyner J. David 4

4 · CVS HEALTH Corp · Filed Mar 2, 2026

Research Summary

AI-generated summary of this filing

Updated

CVS CEO J. David Joyner Surrenders 1,944 Shares for Taxes

What Happened

  • J. David Joyner, President & CEO and Director of CVS Health (CVS), surrendered 1,944 shares on 2026-02-28 to satisfy withholding tax obligations tied to the vesting and settlement of a restricted stock unit (RSU) award.
  • The shares were valued at $79.90 each, for a total of $155,326. This was a tax-withholding disposition, not an open-market sale.

Key Details

  • Transaction date: 2026-02-28; Form 4 filed: 2026-03-02.
  • Price per share: $79.90; shares surrendered: 1,944; total value surrendered: $155,326.
  • Shares owned after transaction: not specified in the filing.
  • Footnote: F1 — shares surrendered to pay withholding taxes upon vesting/settlement of RSUs (tax withholding code F).
  • Filing timeliness: no late filing indicator shown in the report.

Context

  • This was a routine tax-withholding action (often called a "share surrender" or "sell-to-cover") related to RSU vesting, not a discretionary market sale; such transactions are common and generally do not signal insider sentiment about the company’s prospects.

Insider Transaction Report

Form 4
Period: 2026-02-28
Joyner J. David
DirectorPresident and CEO
Transactions
  • Tax Payment

    Common Stock

    [F1]
    2026-02-28$79.90/sh1,944$155,32649,996 total
Holdings
  • Common Stock (RSUs)

    74,534
Footnotes (1)
  • [F1]Surrender of shares in payment of withholding taxes due upon the vesting and settlement of a restricted stock unit award.
Signature
/s/ J. David Joyner|2026-03-02

Documents

1 file
  • 4
    form4.xmlPrimary

    PRIMARY DOCUMENT